A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Nitazoxanide in Adults With Acute Uncomplicated Influenza.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Nitazoxanide (Primary)
- Indications Influenza virus infections
- Focus Registrational; Therapeutic Use
- Sponsors Romark Laboratories
- 20 Dec 2010 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 20 Dec 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 03 Feb 2010 New trial record